1 |
Course Title: |
PHARMACOGENETIC |
2 |
Course Code: |
TTIP6006 |
3 |
Type of Course: |
Optional |
4 |
Level of Course: |
Third Cycle |
5 |
Year of Study: |
1 |
6 |
Semester: |
2 |
7 |
ECTS Credits Allocated: |
5 |
8 |
Theoretical (hour/week): |
2 |
9 |
Practice (hour/week) : |
0 |
10 |
Laboratory (hour/week) : |
0 |
11 |
Prerequisites: |
|
12 |
Recommended optional programme components: |
None |
13 |
Language: |
Turkish |
14 |
Mode of Delivery: |
Face to face |
15 |
Course Coordinator: |
Prof. Dr. MUSTAFA SERTAÇ YILMAZ |
16 |
Course Lecturers: |
|
17 |
Contactinformation of the Course Coordinator: |
sertacyilmaz@uludag.edu.tr +90 224 295 3566 Uludağ Üniversitesi Tıp Fakültesi Tıbbi Farmakoloji Anabilim Dalı, Görükle, Bursa 16059 |
18 |
Website: |
|
19 |
Objective of the Course: |
This course focuses on principles of general pharmacology and pharmacogenetics which may affect the drug metabolism and action. |
20 |
Contribution of the Course to Professional Development |
Administration of the proper drug to the suitable patient via personal drug metabolism that acquired from pharmacogenetic info will decrease side effects and improve health economy. |
Week |
Theoretical |
Practical |
1 |
Introduction to Pharmacology Definition and Basic Concepts |
|
2 |
Definition of Pharmacogenetics, Pharmacogenomics and Basic Concepts |
|
3 |
Individual Treatments and Pharmacogenetics |
|
4 |
Changes in Drug Pharmacokinetics Due to Genetic Factors - Phase I Enzymes |
|
5 |
Changes in Drug Pharmacokinetics Due to Genetic Factors - Phase I Enzymes |
|
6 |
Changes in Drug Pharmacokinetics Due to Genetic Factors - Phase II Enzymes |
|
7 |
Changes in Drug Pharmacokinetics Due to Genetic Factors - Phase II Enzymes |
|
8 |
Drug Pharmacokinetics with Case Examples |
|
9 |
Pharmacogenetics of Transportor Molecules Carrying Drugs - Eflux Transporters |
|
10 |
Pharmacogenetics of Transportor Molecules Carrying Drugs - Uptake Transporters |
|
11 |
Pharmacogenetics of Transportor Molecules Carrying Drugs with Case Examples |
|
12 |
Changes in Drug Pharmacodynamics Due to Genetic Factors - G6PDH Deficiency |
|
13 |
Changes in Drug Pharmacodynamics Due to Genetic Factors - Somatic Gene Variations in Tumor Tissue |
|
14 |
Pharmacogenetic Tests and Clinical Reflections |
|